N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease
US-9512111-B2 · Dec 6, 2016 · US
This page is not indexed by search engines while we improve data quality.
Mattson Matthew N — Human Necessities
Mattson Matthew N holds 2 patents in Human Necessities, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Mattson Matthew N |
| Technology | Human Necessities |
| Patents in slice | 2 |
| Recent patents in slice | 0 |
| First year | 2015 |
| Last year | 2016 |
Representative patents
Notable publications linking Mattson Matthew N to Human Necessities.
N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease
US-9512111-B2 · Dec 6, 2016 · US
N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease
US-9512111-B2 · Dec 6, 2016 · US
N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease
US-9512111-B2 · Dec 6, 2016 · US
N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease
US-9512111-B2 · Dec 6, 2016 · US
Recent filings
Latest patents from Mattson Matthew N in Human Necessities.
N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease
US-9512111-B2 · Dec 6, 2016 · US
N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease
US-9512111-B2 · Dec 6, 2016 · US
N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease
US-9512111-B2 · Dec 6, 2016 · US
N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease
US-9512111-B2 · Dec 6, 2016 · US
N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease
US-9512111-B2 · Dec 6, 2016 · US
Related pages
Navigate to parent entity pages.